Rafael Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Rafael Pharmaceuticals Ownership

Who owns Rafael Pharmaceuticals?

Rafael Pharmaceuticals is owned by Rafael Holdings. It was acquired on January 23, 2019.

Rafael Pharmaceuticals Business Overview

Where is Rafael Pharmaceuticals headquartered?

Rafael Pharmaceuticals is headquartered in Newark, New Jersey.

What sector is Rafael Pharmaceuticals in?

Rafael Pharmaceuticals is a life science company.

When was Rafael Pharmaceuticals founded?

Rafael Pharmaceuticals was founded in 2000.

Life Science M&A Summary in 2019

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.

Join Mergr to view all 245 acquisitions of life science companies in 2019, including 40 acquisitions by private equity firms, and 205 by strategics.

Rafael Pharmaceuticals, Inc.

520 Broad Street,
Newark, New Jersey 07102
United States,
(585) 978-1351
www.rafaelpharma.com

Rafael Pharmaceuticals, Inc. is a clinical stage, metabolic oncology-therapeutics company developing innovative, highly selective and well tolerated anti-cancer agents. Rafael Pharmaceuticals was founded in 2000 and is based in Newark, New Jersey.


 Subscribe to unlock this and 201,882
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.